The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis

European Journal of Endocrinology

Volumn 159, Issue 4, 2008, Pages 423-429

  Piga, M ^a   Cocco, M C ^a   Serra, A ^a   Boi, F ^a   Loy, M ^a   Mariotti, S ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CARDIOLYTE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; POTASSIUM CHLORIDE; PREDNISONE; RADIOACTIVE IODINE; SODIUM IODIDE I 131; TECHNETIUM 99M; THIAMAZOLE; THYROID ANTIBODY; THYROID HORMONE; THYROTROPIN; UNCLASSIFIED DRUG; ANTIARRHYTHMIC AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; AMIODARONE INDUCED THYROTOXICOSIS; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; THYROID SCINTISCANNING; THYROTOXICOSIS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; ECHOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; MIDDLE AGED; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROTOXICOSIS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 54049117169     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0348     Document Type: Article

References (41)

1. Kumar A. Intravenous antiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. Southern Medical Journal 1996 89 779-785.
2. Reiffel JA, Estes NA III, Waldo AL, Prystowsky EN & DiBianco R. A consensus report on antiarrhythmic drug use. Clinical Cardiology 1994 17 103-116.
3. Trip MD, Wiersinga W & Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. American Journal of Medicine 1991 91 507-511.
4. Harjai KJ & Licata AA. Effects of amiodarone on thyroid function. Annals of Internal Medicine 1997 126 63-73.
5. Goldschlager N, Epstein AE, Naccarelli G, Olshansky B & Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Eiectrophysiology. Archives of Internal Medicine 2000 160 1741-1748.
6. Loy M, Perra E, Melis A, Cianchetti ME, Piga M, Serra A, Pinna G & Mariotti S. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Acta Radiologica 2007 48 628-634.
7. Martino E, Bartalena L, Bogazzi F & Braverman LE. The effects of amiodarone on the thyroid. Endocrine Reviews 2001 22 240-254.
8. Bartalena L, Bogazzi F & Martino E. Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge. Clinical Endocrinology 2002 56 23-24.
9. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A & Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. Journal of Clinical Endocrinology and Metabolism 1996 81 2930-2933.
10. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A & Martino E. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clinical Endocrinology 2004 61 494-502.
11. Brennan MD, Erickson DZ, Carney JA & Bahn RS. Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo. Thyroid 1995 5 177-183.
12. Bogazzi F, Bartalena L, Gasperi M, Braverman LE & Martino E. The various effects of amiodarone on thyroid function. Thyroid 2001 11 511-519.
13. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C & Martino E. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997 7 541-545.
14. Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini-Lombardi F, Ceccarelli C, Pinchera A, Bartalena L & Braverman LE. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. Journal of Endocrinological Investigation 2003 26 635-640.
15. Daniels GH. Amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 2001 86 3-8.
16. Eaton SE, Euinton HA, Newman CM, Weetman AP & Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clinical Endocrinology 2002 56 33-38.
17. Martino E, Bartalena L, Mariotti S, Aghini-Lombardi F, Ceccarelli C, Lippi F, Piga M, Loviselli A, Braverman L, Safran M & Pinchera A. Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction. Acta Endocrinologica 1988 119 167-173.
18. Chiu ML, Kronauge JF & Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. Journal of Nuclear Medicine 1990 31 1646-1653.
19. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A & Jones AG. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Research 1990 50 2198-2202.
20. Piwnica-Worms D & Holman BL. Noncardiac applications of hexakis(alkylisonitrile) technetium-99m complexes. Journal of Nuclear Medicine 1990 31 1166-1167.
21. O'Doherty MJ, Kettle AG, Wells P, Collins RE & Coakley AJ. Parathyroid imaging with technetium-99m-sestaMIBI: preoperative localization and tissue uptake studies. Journal of Nuclear Medicine 1992 33 313-318.
22. Sandrock D, Merino M, Norton J, Sandrock D, Merino MJ, Norton JA & Neumann RD. Light- and electron-microscopic analyses of parathyroid tumours explain results of TI-201/Tc-99m parathyroid scintigraphy (abstract). European Journal of Nuclear Medicine 1989 15 410.
23. Boi F, Lai ML, Deias C, Piga M, Serra A, Uccheddu A, Faa G & Mariotti S. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. European Journal of Endocrinology 2003 149 493-498.
24. Kao CH, Lin WY, Wang SJ & Yeh SH. Visualization of suppressed thyroid tissue by Tc-99m MIBI. Clinical Nuclear Medicine 1991 16 812-814.
25. Kao CH, Wang SJ, Liao SQ, Lin WY & Hsu CY. Quick diagnosis of hyperthyroidism with semiquantitative 30-minute technetium-99m-methoxy-isobutyl-isonitrile thyroid uptake. Journal of Nuclear Medicine 1993 34 71-74.
26. Johannessen J. Endocrine organs, part two: the thyroid gland. In Electron Microscopy un Human Medicine, vol 10, pp 27-107. New York: McGraw-Hill, 1981.
27. Fukumoto M. Single-photon agents for tumor imaging: 201TI, 99mTc-MIBI, and 99mTc-tetrofosmin. Annals of Nuclear Medicine 2004 18 79-95.
28. Kroemer G, Dallaporta B & Resche-Rigon M. The mitochondrial death/ life regulator in apoptosis and necrosis. Annual Review of Physiology 1998 60 619-642.
29. Vergote J, Di Benedetto M, Moretti JL, Azaloux H, Kouyoumdjian JC, Kraemer M & Crepin M. Could 99mTc-MIBI be used to visualize the apoptotic MCF7 human breast cancer cells? Cellular and Molecular Biology 2001 47 467-471.
30. Martino E, Aghini-Lombardi F, Mariotti S, Lenziardi M, Baschieri L, Braverman LE & Pinchera A. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. Journal of Endocrinological Investigation 1986 9 201-207.
31. Loviselli A, Velluzzi F, Mossa P, Cambosu MA, Secei G, Atzeni F, Taberlet A, Balestrieri A, Martino E, Grasso L, Songini M, Bottazzo GF & Mariotti S. The Sardinian Autoimmunity Study: 3. Studies on circulating antithyroid antibodies in Sardinian schoolchildren: relationship to goiter prevalence and thyroid function. Thyroid 2001 11 849-857.
32. Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, Braverman LE & Pinchera A. Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 1994 134 2277-2282.
33. Meurisse M, Hamoir E, D'Silva M, Joris J & Hennen G. Amiodarone-induced thyrotoxicosis: is there a place for surgery? World Journal of Surgery 1993 17 622-626 (discussion 627).
34. Mulligan DC, McHenry CR, Kinney W & Esselstyn CB Jr. Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy. Surgery 1993 114 1114-1119.
35. Smyrk TC, Goellner JR, Brennan MD & Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. American Journal of Surgical Pathology 1987 11 197-204.
36. Hiromatsu Y, Ishibashi M, Nishida H, Kawamura S, Kaku H, Baba K, Kaida H & Miyake I. Technetium-99 m sestamibi imaging in patients with subacute thyroiditis. Endocrine Journal 2003 50 239-244.
37. Aktolun C & Bayhan H. Tc-99m MIBI uptake in pulmonary sarcoidosis. Preliminary clinical results and comparison with Ga-67. Clinical Nuclear Medicine 1994 19 1063-1065.
38. Farwell AP, Abend SL, Huang SK, Patwardhan NA & Braverman LE. Thyroidectomy for amiodarone-induced thyrotoxicosis. Journal of the American Medical Association 1990 263 1526-1528.
39. Bogazzi F, Dell'Unto E, Tanda ML, Tomisti L, Cosci C, Aghini-Lombardi F, Sardella C, Pinchera A, Bartalena L & Martino E. Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis. Journal of Endocrinological Investigation 2006 29 694-699.
40. Brian SR, Cheng DW & Goldberg PA. Unusual case of amiodarone-induced thyrotoxicosis: 'illicit' use of a technetium scan to diagnose a transiently toxic thyroid nodule. Endocrine Practice 2007 13 413-416.
41. Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A & Martino E. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clinical Endocrinology 2007 67 533-537.